A. Tavakkol

发表

Institutional investors and the information content of earnings announcements: the case of Poland

Piotr Korczak, A. Tavakkol, 2004 .

Onychomycosis: diagnosis and definition of cure.

David G Armstrong, Roderick J Hay, Mahmoud Ghannoum, 2007, Journal of the American Academy of Dermatology.

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.

B. Elewski, J. Schlessinger, M. Gold, 2020 .

Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild-to-moderate distal subungual onychomycosis: A randomized, multi-center, double-blind, vehicle-controlled phase 3 study.

Aditya K. Gupta, D. Pariser, S. Kempers, 2020, Journal of the American Academy of Dermatology.

Safety and Tolerability of Luliconazole Solution 10-Percent in Patients with Moderate to Severe Distal Subungual Onychomycosis

T. Jones, A. Tavakkol, 2013, Antimicrobial Agents and Chemotherapy.

Toenail assessment tool for quantitation of visibly infected mycotic nail plate in onychomycosis.

F. Kianifard, L. Harkless, R. Pollak, 2007, Cutis.

Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor

James T. Elder, J. Varani, C. Zouboulis, 1999, Archives of Dermatological Research.

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis

F. Kianifard, A. Landsman, A. Tavakkol, 2007, The Journal of dermatological treatment.

Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism.

K. Cooper, L. Chan, A. Tavakkol, 1992, The Journal of investigative dermatology.

Protooncogene expression in normal and psoriatic skin.

James T. Elder, M. Wicha, J. Voorhees, 1990, The Journal of investigative dermatology.

Porcine insulin-like growth factor-I (pIGF-I): complementary deoxyribonucleic acid cloning and uterine expression of messenger ribonucleic acid encoding evolutionarily conserved IGF-I peptides.

R. Simmen, F. Simmen, A. Tavakkol, 1988, Molecular endocrinology.

Molecular cloning of porcine alpha 1-microglobulin/HI-30 reveals developmental and tissue-specific expression of two variant messenger ribonucleic acids.

A. Tavakkol, 1991, Biochimica et biophysica acta.

Treatment of Chronic Rhinosinusitis with High‐Dose Oral Terbinafine: A Double Blind, Placebo‐Controlled Study

S. Zinreich, D. Kennedy, F. Kuhn, 2005, The Laryngoscope.

Forward Risk Premia and the Maturity of Contracts: A Note

A. Tavakkol, Ali Fatemi, 1992 .

The OnyCOE-t™ questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis

F. Kianifard, A. Tavakkol, S. Mathias, 2006, Health and quality of life outcomes.

A Study of the Curriculum Content and Administration of the International Financial Management Course.

D. Andrus, A. Tavakkol, 1996 .

The Use of Ozone as an Oxidizing Agent to Evaluate Antioxidant Activities of Natural Substrates

D. Scherl, A. Tavakkol, Q. He, 2004, Skin Pharmacology and Physiology.

Growth factor and proto-oncogene expression in psoriasis.

James T. Elder, J. Voorhees, G. Fisher, 1990, The Journal of investigative dermatology.

Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin.

James T. Elder, J. Voorhees, G. Fisher, 1992, The Journal of investigative dermatology.

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.

B. Elewski, J. Nyirady, Héctor Cáceres, 2008, Journal of the American Academy of Dermatology.

Evidence for a direct role for sialic acid in the attachment of encephalomyocarditis virus to human erythrocytes.

A. Tavakkol, A. T. Burness, 1990, Biochemistry.

A phase 2, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of orally administered VT‐1161 in the treatment of recurrent vulvovaginal candidiasis

P. Nyirjesy, J. Sobel, T. Degenhardt, 2018, American journal of obstetrics and gynecology.

The Impact of Weekly Time Period Choice on Volume and Size Cross-Autocorrelations

E. Higgins, A. Tavakkol, 2004 .

Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.

James T. Elder, G. Fisher, S. Kang, 1995, The Journal of investigative dermatology.

A randomized, placebo‐ and active‐controlled, parallel‐group, multicentre, investigator‐blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

B. Elewski, J. Schlessinger, R. Pollak, 2012, The British journal of dermatology.

Skin Concentrations and Pharmacokinetics of Posaconazole after Oral Administration

A. Tavakkol, G. Krishna, M. Martinho, 2010, Antimicrobial Agents and Chemotherapy.

Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I.

T. Hamilton, J. Voorhees, B. Nelson, 1994, Archives of dermatology.

Delivery of vitamin E to the skin by a novel liquid skin cleanser: comparison of topical versus oral supplementation.

N. Soliman, T. Polefka, A. Tavakkol, 2004, Journal of cosmetic science.

Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study.

T. Jones, S. Kempers, M. Jarratt, 2013, Cutis.

Luliconazole Demonstrates Potent In Vitro Activity against Dermatophytes Recovered from Patients with Onychomycosis

A. Fothergill, D. McCarthy, N. Wiederhold, 2014, Antimicrobial Agents and Chemotherapy.

Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis

A. Tavakkol, R. Scher, N. Nakamura, 2014, Mycoses.

Moderate to Severe Distal Subungual Onychomycosis

T. Jones, A. Tavakkol, 2013 .

Molecular analysis of dermatophytes suggests spread of infection among household members.

E. Warshaw, M. Ghannoum, S. Evans, 2013, Cutis.

Tinea capitis in the United States: Diagnosis, treatment, and costs.

D. Suh, S. Friedlander, L. Vo, 2006, Journal of the American Academy of Dermatology.

The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.

Aditya K. Gupta, A. Tavakkol, J. Ryder, 2005, Journal of drugs in dermatology : JDD.

Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial.

F. Kianifard, L. Harkless, R. Pollak, 2006, Journal of the American Podiatric Medical Association.

Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.

F. Kianifard, A. Tavakkol, S. Fellman, 2006, The American journal of geriatric pharmacotherapy.

Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality

B. Elewski, A. Tavakkol, 2005, Therapeutics and clinical risk management.

Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta‐analysis of efficacy for continuous and intermittent regimens

Aditya K. Gupta, A. Tavakkol, M. Paquet, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

A comparison of KOH and culture results from two mycology laboratories for the diagnosis of onychomycosis during a randomized, multicenter clinical trial: a subset study.

F. Kianifard, A. Tavakkol, B. Arnold, 2005, Journal of the American Podiatric Medical Association (Print).

Differential Expression of Protein Kinase C Isoenzymes in Normal and Psoriatic Adult Human Skin: Reduced Expression of Protein Kinase C-βII in Psoriasis

James T. Elder, D. Burns, N. Reynolds, 1993 .

The effects of prolonged use of surfactants on the skin of normal and photo‐exposed hairless mice *

T. Polefka, B. M. Morrison, A. Tavakkol, 1998, Contact dermatitis.

Determination of Posaconazole Levels in Toenails of Adults with Onychomycosis following Oral Treatment with Four Regimens of Posaconazole for 12 or 24 Weeks

A. Tavakkol, G. Krishna, M. Martinho, 2011, Antimicrobial Agents and Chemotherapy.

Treatment of Toenail Onychomycosis with Oral Terbinafine Plus Aggressive Debridementa Large, Randomized,

F. Kianifard, L. Harkless, R. Pollak, 2006 .

Effects of environmentally realistic levels of ozone on stratum corneum function

T. Polefka, A. Tavakkol, S. A. Ansari, 2006, International journal of cosmetic science.

Vitamin E Delivery to Human Skin by a Rinse-Off Product: Penetration of α-Tocopherol versus Wash-Out Effects of Skin Surface Lipids

P. Elsner, J. Thiele, T. Polefka, 2004, Skin Pharmacology and Physiology.

Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin.

James T. Elder, D. Danielpour, G. Fisher, 1992, The Journal of investigative dermatology.

Phosphoinositide-mediated signal transduction in normal and psoriatic epidermis.

James T. Elder, J. Voorhees, G. Fisher, 1990, The Journal of investigative dermatology.

Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro.

James T. Elder, J. Voorhees, A. Tavakkol, 1991, The Journal of biological chemistry.

A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skinin vivo and cultured skin cellsin vitro

J. Voorhees, C. Zouboulis, A. Tavakkol, 2004, Molecular Biology Reports.

Somatic cell mapping and restriction fragment length polymorphism analysis of bovine insulin-like growth factor I.

D. Threadgill, J. Womack, R. Simmen, 1991, Journal of animal science.

Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-gamma 1 in retinoic acid-treated human skin.

J. Voorhees, C. Griffiths, R. Palmer, 1992, The Journal of investigative dermatology.

Differential regulation of retinoic acid receptors and binding proteins in human skin.

James T. Elder, P. Chambon, A. Krust, 1992, The Journal of investigative dermatology.

Retinoic acid receptors and binding proteins in human skin.

James T. Elder, P. Chambon, A. Krust, 1992, The Journal of investigative dermatology.

Topical all-trans retinoic acid (RA) induces an early, coordinated increase in RA-inducible skin-specific gene/psoriasin and cellular RA-binding protein II mRNA levels which precedes skin erythema

J. Voorhees, C. Zouboulis, C. Orfanos, 1996, Archives of Dermatological Research.

Bioconversion of vitamin E acetate in human skin.

T. Polefka, M. Dobke, A. Tavakkol, 2001, Current problems in dermatology.

Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo.

T. Hamilton, J. Voorhees, N. Reynolds, 1993, The Journal of pharmacology and experimental therapeutics.

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

P. Nyirjesy, J. Sobel, T. Degenhardt, 2018, American Journal of Obstetrics and Gynecology.

The CONTROL study: A randomized, double-blind vehicle-controlled Phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis.

D. Murrell, L. Castelo-Soccio, A. Mendelsohn, 2022, Journal of the American Academy of Dermatology.